Lv12
60 积分 2024-03-09 加入
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer
2个月前
已完结
TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling
2个月前
已关闭
IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects
2个月前
已完结
Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer
5个月前
已完结
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment
5个月前
已完结
A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
5个月前
已完结
Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer
5个月前
已完结
An updated patent review of IDO1 inhibitors for cancer (2018–2022)
5个月前
已完结
Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis
5个月前
已完结
USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer
8个月前
已完结
皖公网安备34019202002308
